Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1904459

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1904459

Lacrimal Devices Market Size, Share, and Growth Analysis, By Product (Intubation Sets, Stents and Tubes), By Application (Glaucoma, Dry Eye), By End-use, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Lacrimal Devices Market size was valued at USD 171.47 Million in 2024 and is poised to grow from USD 177.98 Million in 2025 to USD 239.86 Million by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across demographics. The rising incidence of eye disorders has spurred increased demand for advanced solutions, including punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and refined surgical techniques have also enhanced patient outcomes, further fueling market expansion. The aging population, coupled with a rise in age-related eye conditions, ensures sustained growth in this sector. Manufacturers and healthcare providers are dedicated to innovative developments that cater to the evolving needs of patients suffering from lacrimal disorders, focusing on enhancing care quality and comfort. Regulatory influences and reimbursement policies significantly shape market dynamics, presenting promising opportunities for companies in the ophthalmic devices landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily propelled by the rising prevalence of eye disorders on a global scale. Contributing factors include an aging population, lifestyle changes, and the surge in screen time, all of which lead to conditions such as dry eye syndrome and various lacrimal system disorders. As awareness of these issues grows, so does the demand for lacrimal devices designed to assist in the diagnosis and treatment of these conditions. This heightened need not only enhances the focus on innovative solutions but also significantly fuels the overall expansion of the lacrimal devices market.

Restraints in the Lacrimal Devices Market

A significant challenge facing the lacrimal devices market is the rigorous regulatory environment, which often results in delays when seeking approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, impose strict standards for medical devices, leading to prolonged timelines for bringing innovations to market. This complex regulatory framework can hinder both the pace of innovation and the overall growth of the market, affecting established companies as well as new market entrants. Such constraints can restrict opportunities for advancement and limit the ability to respond swiftly to evolving patient needs and technological advancements.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is experiencing a pronounced shift towards minimally invasive procedures, reflecting a growing preference among patients and healthcare providers for options that ensure quicker recovery times and enhanced comfort. This trend is catalyzing innovation, leading to the development of advanced minimally invasive lacrimal devices, including microendoscopes and specialized catheters designed to effectively treat lacrimal system disorders. As the demand for procedures that minimize postoperative complications continues to rise, manufacturers are increasingly investing in research and development to align product offerings with these evolving patient care preferences, thereby shaping the future landscape of the lacrimal devices market.

Product Code: SQMIG35G2212

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Intubation Sets
  • Stents and Tubes
  • Cannula and Spatula
  • Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Glaucoma
  • Dry Eye
  • Lacrimal Gland Inflammation
  • Epiphora
  • Others

Global Lacrimal Devices Market Size by End-use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2026-2033)

  • North America (Product, Application, End-use)
    • US
    • Canada
  • Europe (Product, Application, End-use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • FCI Ophthalmics (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kaneka Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Group (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVI (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rumex International (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bess Medical Technology GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch and Lomb Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OASIS Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beaver-Visitec International (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FC Optics Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptiMedica Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diamatrix Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FCI S.A.S. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eye Kon Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!